| | | | | | | |
 | MODERNA, INC. | -2.01% | 1.50% | 5.42% | 18.74% | 746.82% | 72 745 |
 | LONZA GROUP AG | 0.04% | 9.75% | 17.24% | -15.55% | 33.74% | 42 787 |
| IQVIA HOLDINGS INC. | 0.42% | 2.62% | 12.00% | -3.92% | 44.62% | 42 622 |
| ALNYLAM PHARMACEUTICALS, INC. | -0.09% | 1.33% | -2.64% | 75.16% | 101.68% | 28 465 |
| SEAGEN INC. | 0.70% | 6.98% | 9.46% | 10.23% | 24.56% | 26 117 |
 | CELLTRION, INC. | 0.91% | 1.71% | 3.93% | 14.88% | 5.85% | 19 410 |
| ICON PUBLIC LIMITED COMPANY | -1.22% | -1.37% | 17.50% | -13.20% | 31.97% | 18 635 |
| BIO-TECHNE CORPORATION | 1.08% | -0.58% | -2.04% | -11.53% | 48.68% | 12 744 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | 0.33% | 0.79% | 12.48% | -23.82% | 56.18% | 12 470 |
| UNITED THERAPEUTICS CORPORATION | -1.72% | -0.77% | -6.62% | 29.26% | 178.63% | 11 835 |
| QIAGEN N.V. | -1.22% | -0.62% | -1.14% | 1.42% | 43.48% | 11 226 |
 | GENSCRIPT BIOTECH CORPORATION | 1.38% | 5.96% | 18.11% | 22.04% | 66.76% | 7 929 |
| MEDPACE HOLDINGS, INC. | -1.78% | -2.38% | 5.31% | 31.96% | 152.97% | 6 938 |
| BACHEM HOLDING AG | 0.73% | 1.28% | 3.88% | -22.62% | 153.82% | 6 642 |
| ROIVANT SCIENCES LTD. | 2.15% | -2.62% | 7.01% | 27.99% | --.--% | 6 202 |
| | | | | | | |
| | Durchschnitt | -0.02% | 1.57% | 6.66% | 9.40% | 120.70% | |
| | Gewichteter Durchschnitt nach Marktkapitalisierung | -0.35% | 2.68% | 7.67% | 10.16% | 213.54% | |
Google
Twitter
Facebook
Apple
English (USA)
English (UK)
English (Canada)
Deutsch (Schweiz)
Español
Français (France)
Italiano
Nederlands (Nederland)
Nederlands (België)
Bericht
